Mycograb for the treatment of invasive candidiasis.
Herbrecht
Raoul
R
Fohrer
Cécile
C
Nivoix
Yasmine
Y
D000666:Amphotericin B / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002177:Candidiasis / Q000188:drug therapy* / Q000652:urine; D004338:Drug Combinations; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012107:Research Design; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004338:Drug Combinations; D018841:HSP90 Heat-Shock Proteins; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; D011994:Recombinant Proteins; C068538:liposomal amphotericin B; D000666:Amphotericin B; C512268:efungumab